Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 9/20 | 0.43 |
| ▸ | HTR2B | P41595 | 6/20 | 0.42 |
| ▸ | HTR2A | P28223 | 4/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23185437 | 0.96 | MEN1 (0.46) | HTR2CHTR2BHTR2AMAOBMEN1 | |
| SCHEMBL7563619 | 0.87 | HTR2C (0.40) | HTR2CHTR2BHTR2AMAOBMEN1 | |
| SCHEMBL27846715 | 0.82 | DPP4 (0.42) | HTR2C | |
| SCHEMBL15254847 | 0.80 | MAOB (0.62) | HTR2CHTR2BHTR2AMAOB | |
| SCHEMBL8036763 | 0.80 | MEN1 (0.46) | HTR2CHTR2BHTR2AMAOBMEN1 | |
| SCHEMBL21535613 | 0.79 | MAOB (0.44) | HTR2CHTR2BHTR2AMAOB | |
| SCHEMBL12505576 | 0.79 | HTR2C (0.50) | HTR2CHTR2BHTR2AMAOBGRIA4 | |
| SCHEMBL27347061 | 0.79 | GRIA4 (0.37) | HTR2CHTR2BHTR2AMAOBMEN1 | |
| SCHEMBL20348840 | 0.77 | SLC6A2 (0.46) | HTR2CHTR2BHTR2A | |
| SCHEMBL839081 | 0.76 | MEN1 (0.50) | HTR2CHTR2BHTR2AMAOBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2590973-B1 | SOLIFENACIN SALTS | CRYSTAL PHARMA SAU (ES) | 2016-08-31 | — | — | EP | disclosed |
| US-8765785-B2 | Solifenacin salts | CRYSTAL PHARMA, S.A.U. (ES) | 2014-07-01 | — | — | US | disclosed |
| US-20130203804-A1 | SOLIFENACIN SALTS | CRYSTAL PHARMA, S.A.U. (ES) | 2013-08-08 | — | — | US | disclosed |
| EP-2590973-A1 | SOLIFENACIN SALTS | Crystal Pharma S.A.U (ES) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012079583-A1 | SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS CO FOR CARBONYLATION REACTIONS | AARHUS UNIVERSITET (DK) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012004264-A1 | SOLIFENACIN SALTS | RAGACTIVES, S.L.U. (ES) | 2012-01-12 | — | — | WO | disclosed |
| WO-2010031408-A2 | GEL COMPOSITIONS | AARHUS UNIVERSITET (DK) | 2010-03-25 | — | — | WO | disclosed |